Brett Premack - Sirona Biochem Scientific Consultant

SBM Stock  CAD 0.07  0.01  13.33%   

Insider

Brett Premack is Scientific Consultant of Sirona Biochem Corp
Address 595 Burrard Street, Vancouver, BC, Canada, V7X 1L4
Phone604 641 4466
Webhttps://www.sironabiochem.com

Sirona Biochem Management Efficiency

The company has return on total asset (ROA) of (1.4811) % which means that it has lost $1.4811 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (98.1047) %, meaning that it generated substantial loss on money invested by shareholders. Sirona Biochem's management efficiency ratios could be used to measure how well Sirona Biochem manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sirona Biochem's Net Tangible Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 1.7 M in 2024, whereas Total Assets are likely to drop slightly above 882.4 K in 2024.
Sirona Biochem Corp has accumulated 637.65 K in total debt with debt to equity ratio (D/E) of 470.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sirona Biochem Corp has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sirona Biochem until it has trouble settling it off, either with new capital or with free cash flow. So, Sirona Biochem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sirona Biochem Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sirona to invest in growth at high rates of return. When we think about Sirona Biochem's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

David PaisWishpond Technologies
N/A
Michael ReinhartQuisitive Technology Solutions
N/A
Jana SchmidtQuisitive Technology Solutions
N/A
Dennis ZeladaWishpond Technologies
N/A
Glenn BrandtRogers Communications
N/A
Jordan GutierrezWishpond Technologies
N/A
BHK MBAWishpond Technologies
42
Paulina MolnarRogers Communications
N/A
Barbara FranovicWilkinsData Communications Management
N/A
FCA FCARogers Communications
57
Ali TajskandarWishpond Technologies
N/A
Deborah CarterRossRenoworks Software
N/A
Lisa DurocherRogers Communications
57
Ronald McKenzieRogers Communications
N/A
Shelly AnwyllData Communications Management
N/A
Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada. SIRONA BIOCHEM operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. Sirona Biochem Corp (SBM) is traded on TSX Venture Exchange in Canada and employs 4 people. Sirona Biochem is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Sirona Biochem Corp Leadership Team

Elected by the shareholders, the Sirona Biochem's board of directors comprises two types of representatives: Sirona Biochem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sirona. The board's role is to monitor Sirona Biochem's management team and ensure that shareholders' interests are well served. Sirona Biochem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sirona Biochem's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CGA, CFO Director
Graldine DeliencourtGodefroy, Chief Director
Michelle MBA, VP Operations
Brett Premack, Scientific Consultant

Sirona Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sirona Biochem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sirona Stock Analysis

When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.